Djavad Mowafaghian Centre for Brain Health | October 31, 2022
The newly established UBC MATRIX-N (Multidisciplinary Alliance for Translational Research and Innovation in Neuropsychiatry) research excellence cluster recently…
Jazz Pharmaceuticals and Zymeworks Inc entered into a $50 million licensing agreement over zanidatamab, Zymeworks’ bispecific antibody targeting HER2,…